Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Waters

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Diabetologia|October 1, 1992
Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic controlP J Waters, M D Flynn, R J Corrall, et al.
Biochemical Society Transactions|November 1, 1992
Factors affecting the assay of urinary free and bound sialic acidP J Waters, E M Lewry, A P Brimble, et al.
Molecular Genetics and Metabolism|March 18, 2000
Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotypeP J Waters, M A Parniak, B R Akerman, et al.
Biochemical Society Transactions|May 1, 1993
Diabetes-related changes in sialic acid content of leucocytes: an assay-dependent artefact?P J Waters, M D Flynn, C A Pennock, et al.
American Journal of Human Genetics|December 18, 1997
Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlationsE Kayaalp, E Treacy, P J Waters, et al.
Journal of Inherited Metabolic Disease|June 29, 1999
Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: a mechanism underlying phenylketonuriaP J Waters, M A Parniak, B R Akerman, et al.
Neuropediatrics|November 11, 2008
Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRIN Brunetti-Pierri, K Selby, M O'Sullivan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1995
Decreased sialidase activity in mononuclear leucocytes of type 1 diabetic subjects: relationship to diabetic complications and glycaemic controlP J Waters, M D Flynn, C A Pennock, et al.
Neuropediatrics|July 4, 2007
Isolated sulfite oxidase deficiency in the newborn: lactic acidaemia and leukoencephalopathyS N Basheer, P J Waters, C W Lam, et al.
Pediatric Research|October 6, 1997
Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-13C]phenylalanine oxidation rates in vivo: a pilot studyE P Treacy, J J Delente, G Elkas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Diabetologia|October 1, 1992
Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic controlP J Waters, M D Flynn, R J Corrall, et al.
Biochemical Society Transactions|November 1, 1992
Factors affecting the assay of urinary free and bound sialic acidP J Waters, E M Lewry, A P Brimble, et al.
Molecular Genetics and Metabolism|March 18, 2000
Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotypeP J Waters, M A Parniak, B R Akerman, et al.
Biochemical Society Transactions|May 1, 1993
Diabetes-related changes in sialic acid content of leucocytes: an assay-dependent artefact?P J Waters, M D Flynn, C A Pennock, et al.
American Journal of Human Genetics|December 18, 1997
Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlationsE Kayaalp, E Treacy, P J Waters, et al.
Journal of Inherited Metabolic Disease|June 29, 1999
Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: a mechanism underlying phenylketonuriaP J Waters, M A Parniak, B R Akerman, et al.
Neuropediatrics|November 11, 2008
Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRIN Brunetti-Pierri, K Selby, M O'Sullivan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1995
Decreased sialidase activity in mononuclear leucocytes of type 1 diabetic subjects: relationship to diabetic complications and glycaemic controlP J Waters, M D Flynn, C A Pennock, et al.
Neuropediatrics|July 4, 2007
Isolated sulfite oxidase deficiency in the newborn: lactic acidaemia and leukoencephalopathyS N Basheer, P J Waters, C W Lam, et al.
Pediatric Research|October 6, 1997
Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-13C]phenylalanine oxidation rates in vivo: a pilot studyE P Treacy, J J Delente, G Elkas, et al.
Pageof 3